A Device for the Rapid Detection of Benzodiazepines and Synthetic Cannabinoids via Fluorescence Spectroscopy and Machine Learning

Introduction: Drug abuse is a worsening societal issue across the globe. In the UK, the abuse of Benzodiazepines and Synthetic Cannabinoids is particularly prevalent, especially in healthcare and custodial settings, and there is currently no solution to quickly detect these substances for harm reduc...

Full description

Saved in:
Bibliographic Details
Main Authors: A. Power, M. Gardner, C. Pudney
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Emerging Trends in Drugs, Addictions, and Health
Online Access:http://www.sciencedirect.com/science/article/pii/S2667118223000612
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850256800501202944
author A. Power
M. Gardner
C. Pudney
author_facet A. Power
M. Gardner
C. Pudney
author_sort A. Power
collection DOAJ
description Introduction: Drug abuse is a worsening societal issue across the globe. In the UK, the abuse of Benzodiazepines and Synthetic Cannabinoids is particularly prevalent, especially in healthcare and custodial settings, and there is currently no solution to quickly detect these substances for harm reduction. Methods: We are developing a portable and rapid device that utilizes Fluorescence Spectroscopy and Machine Learning to detect Benzodiazepines and Synthetic Cannabinoids in a variety of media, including saliva. The device will be able to distinguish between variants of a given drug to provide an informative output to the end user. Results: Development of the first prototype of the device is nearing completion, and lab data has been collected for training the device's drug-detecting predictive model. Current experiments with established supervised-learning algorithms show favourable results in distinguishing Synthetic Cannabinoids. Trials of the device in UK drug hotspots are imminent and will result in a significant data collection of the scans performed and the predictions that the model made per scan. This will provide us with an unprecedented insight into the pervasiveness of illegal drug use in the UK and drive improvements for future iterations of the device. Conclusions: We feel that this is a crucial and promising technology for harm reduction to stem the flow of drugs to the most vulnerable in society.
format Article
id doaj-art-628a9693bd374bf5814904ddf0f8ea9a
institution OA Journals
issn 2667-1182
language English
publishDate 2024-12-01
publisher Elsevier
record_format Article
series Emerging Trends in Drugs, Addictions, and Health
spelling doaj-art-628a9693bd374bf5814904ddf0f8ea9a2025-08-20T01:56:34ZengElsevierEmerging Trends in Drugs, Addictions, and Health2667-11822024-12-01410011010.1016/j.etdah.2023.100110A Device for the Rapid Detection of Benzodiazepines and Synthetic Cannabinoids via Fluorescence Spectroscopy and Machine LearningA. Power0M. Gardner1C. Pudney2University of Bath, UKUniversity of Bath, UKUniversity of Bath, UKIntroduction: Drug abuse is a worsening societal issue across the globe. In the UK, the abuse of Benzodiazepines and Synthetic Cannabinoids is particularly prevalent, especially in healthcare and custodial settings, and there is currently no solution to quickly detect these substances for harm reduction. Methods: We are developing a portable and rapid device that utilizes Fluorescence Spectroscopy and Machine Learning to detect Benzodiazepines and Synthetic Cannabinoids in a variety of media, including saliva. The device will be able to distinguish between variants of a given drug to provide an informative output to the end user. Results: Development of the first prototype of the device is nearing completion, and lab data has been collected for training the device's drug-detecting predictive model. Current experiments with established supervised-learning algorithms show favourable results in distinguishing Synthetic Cannabinoids. Trials of the device in UK drug hotspots are imminent and will result in a significant data collection of the scans performed and the predictions that the model made per scan. This will provide us with an unprecedented insight into the pervasiveness of illegal drug use in the UK and drive improvements for future iterations of the device. Conclusions: We feel that this is a crucial and promising technology for harm reduction to stem the flow of drugs to the most vulnerable in society.http://www.sciencedirect.com/science/article/pii/S2667118223000612
spellingShingle A. Power
M. Gardner
C. Pudney
A Device for the Rapid Detection of Benzodiazepines and Synthetic Cannabinoids via Fluorescence Spectroscopy and Machine Learning
Emerging Trends in Drugs, Addictions, and Health
title A Device for the Rapid Detection of Benzodiazepines and Synthetic Cannabinoids via Fluorescence Spectroscopy and Machine Learning
title_full A Device for the Rapid Detection of Benzodiazepines and Synthetic Cannabinoids via Fluorescence Spectroscopy and Machine Learning
title_fullStr A Device for the Rapid Detection of Benzodiazepines and Synthetic Cannabinoids via Fluorescence Spectroscopy and Machine Learning
title_full_unstemmed A Device for the Rapid Detection of Benzodiazepines and Synthetic Cannabinoids via Fluorescence Spectroscopy and Machine Learning
title_short A Device for the Rapid Detection of Benzodiazepines and Synthetic Cannabinoids via Fluorescence Spectroscopy and Machine Learning
title_sort device for the rapid detection of benzodiazepines and synthetic cannabinoids via fluorescence spectroscopy and machine learning
url http://www.sciencedirect.com/science/article/pii/S2667118223000612
work_keys_str_mv AT apower adevicefortherapiddetectionofbenzodiazepinesandsyntheticcannabinoidsviafluorescencespectroscopyandmachinelearning
AT mgardner adevicefortherapiddetectionofbenzodiazepinesandsyntheticcannabinoidsviafluorescencespectroscopyandmachinelearning
AT cpudney adevicefortherapiddetectionofbenzodiazepinesandsyntheticcannabinoidsviafluorescencespectroscopyandmachinelearning
AT apower devicefortherapiddetectionofbenzodiazepinesandsyntheticcannabinoidsviafluorescencespectroscopyandmachinelearning
AT mgardner devicefortherapiddetectionofbenzodiazepinesandsyntheticcannabinoidsviafluorescencespectroscopyandmachinelearning
AT cpudney devicefortherapiddetectionofbenzodiazepinesandsyntheticcannabinoidsviafluorescencespectroscopyandmachinelearning